– FRANCE, Nantes – OSE Immunotherapeutics SA (EPA: OSE) today announced the nomination of Dr. Eric Leire (MD) for election to its Board as an independent Director.
The company also announced the nominations of CEO Nicolas Poirier and CFO Anne-Laure Autret-Cornet, to its Board of Directors.
About Eric Leire
Eric Leire brings professional international experience, both in the US and in Europe, in biotechnology, and in the pharmaceutical industry. He is the President and CEO of Genflow Biosciences Ltd (listed on LSE: GENF / gene therapy, senescence domain). Previously, he was Chairman, President, and CEO of two companies in the US: Enochian Biosciences (listed on Nasdaq ENOB / cell and gene therapy, VIH, and cancer) and DanDrit Biotech (listed on OTCQB). He formerly held the position of Marketing manager in the US and Europe pharmaceutical industry (Pfizer, Schering Plough, Boots Pharma). Through his operational experience in venture capital funds in the health field at Medwell Capital (Canada) and Biofund Venture (Denmark), he has developed biotech companies financed by investment funds.
Eric Leire is a Medical Doctor (Grenoble University), holder of a postgraduate diploma (DESS) in Health law (Sceaux University). He spent 3 years as a researcher at the Harvard AIDS Institute. He holds an MBA from HEC (ISA) and from Kellogg Graduate School of Management (Chicago). Eric Leire is an American and French citizen.
ABOUT OSE Immunotherapeutics
OSE Immunotherapeutics is a biotech company dedicated to developing first-in-class assets in immuno-oncology and immuno-inflammation.
Source: www.ose-immuno.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
